Bilal Çağdaş Seven
Research Subjects
Bilal Çağdaş Seven has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bahar Uncu Ulu
Hematology and Bone Marrow Transplantation Unit, Ankara Oncology Training and Research Hospital, Health Sciences University, Ankara 06170, Turkey
1 shared publication - Derya Yenibertiz
Department of Pulmonology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye
1 shared publication - Dicle İsKender
Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey
1 shared publication - Esma Sevil Akkurt
Department of Chest Diseases, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara, Türkiye
1 shared publication - Fevzi Altuntaş
Hematology and Bone Marrow Transplantation Unit, Ankara Oncology Training and Research Hospital, Health Sciences University, Ankara 06170, Turkey
1 shared publication - Mehmet Sinan Dal
Sağlık bilimleri üniversitesi abdurrahman yurtaslan onkoloji hastanesi hematoloji kliniği
1 shared publication
Latest Publications
- 22 May 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (3) , 504-512
Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation
Aims: Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infectious complications due to immunosuppression and delayed immune reconstitution, with pneumonia remaining a major cause of early morbidity and mortality. Composite inflammation- and protein-based biomarkers, including the C-reactive protein-to-albumin ratio (CAR) and fibrinogen-to-albumin ratio (FAR), have prognostic value in oncology, but their role in predicting pneumonia and survival after allo-HSCT is unclear.Methods: This retrospective, single-center study included 203 adult allo-HSCT recipients treated between 2020 and 2023. Pre transplant inflammatory and protein-based biomarkers were assessed 7-14 days before transplantation, and Cox proportional hazards regression was used to identify independent predictors of one-year post-transplant pneumonia and mortality.Results: Pneumonia occurred in 17.7% of patients, and one-year mortality was 41.9%. Although lower albumin, hemoglobin, and platelet levels and higher procalcitonin (PCT) concentrations were associated with pneumonia in univariate analyses, no biomarker independently predicted post-transplant pneumonia after multivariate adjustment. In contrast, pre-transplant PCT (HR=1.020, p
- 22 May 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (3) , 504-512
Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation
Aims: Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infectious complications due to immunosuppression and delayed immune reconstitution, with pneumonia remaining a major cause of early morbidity and mortality. Composite inflammation- and protein-based biomarkers, including the C-reactive protein-to-albumin ratio (CAR) and fibrinogen-to-albumin ratio (FAR), have prognostic value in oncology, but their role in predicting pneumonia and survival after allo-HSCT is unclear.Methods: This retrospective, single-center study included 203 adult allo-HSCT recipients treated between 2020 and 2023. Pre transplant inflammatory and protein-based biomarkers were assessed 7-14 days before transplantation, and Cox proportional hazards regression was used to identify independent predictors of one-year post-transplant pneumonia and mortality.Results: Pneumonia occurred in 17.7% of patients, and one-year mortality was 41.9%. Although lower albumin, hemoglobin, and platelet levels and higher procalcitonin (PCT) concentrations were associated with pneumonia in univariate analyses, no biomarker independently predicted post-transplant pneumonia after multivariate adjustment. In contrast, pre-transplant PCT (HR=1.020, p